Rainer Lenhard
Directeur/Membre du Conseil chez ADVANZ PHARMA CORP. LIMITED
Profil
Rainer joined in June, 2019.
He is Partner and Head of the DACH region with focus on Nordic Capital’s core sectors Healthcare, Technology & Payments and Financial Services.
Rainer joined from Goldman Sachs where he was Managing Director focusing on European healthcare companies.
He is of German origin and started his career at McKinsey & Company, working across various industries in the DACH region.
Rainer studied business administration at WHU Koblenz and holds a doctorate/PhD from Friedrich-Alexander-Universität Erlangen-Nürnberg.
Postes actifs de Rainer Lenhard
| Sociétés | Poste | Début |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Directeur/Membre du Conseil | - |
| NC Advisory GmbH | Private Equity Investor | 01/06/2019 |
Anciens postes connus de Rainer Lenhard
| Sociétés | Poste | Fin |
|---|---|---|
Goldman Sachs Bank Europe SE (Germany)
 Goldman Sachs Bank Europe SE (Germany) Investment Banks/BrokersFinance Goldman Sachs Bank Europe SE (Germany) (GS Bank Europe-Germany) is the Germany-based broker-dealer subsidiary of Goldman Sachs (Cayman) Holding Co., which is owned by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. Headquartered in Frankfurt, GS Bank Europe-Germany was founded in 1990 and provides prime brokerage and securities underwriting services. | Directeur/Membre du Conseil | 31/05/2019 |
Formation de Rainer Lenhard
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
| WHU-Otto Beisheim School of Management | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| NC Advisory GmbH | Finance |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
Goldman Sachs Bank Europe SE (Germany)
Goldman Sachs Bank Europe SE (Germany) Investment Banks/BrokersFinance Goldman Sachs Bank Europe SE (Germany) (GS Bank Europe-Germany) is the Germany-based broker-dealer subsidiary of Goldman Sachs (Cayman) Holding Co., which is owned by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. Headquartered in Frankfurt, GS Bank Europe-Germany was founded in 1990 and provides prime brokerage and securities underwriting services. | Finance |